window.pageData = {"stock":{"_id":3000000012284,"stockCode":"012284","shortName":"光大保德信健康优加混合A","fundSecondLevel":"hybrid","stockType":"fund","areaCode":"cn","market":"a","tickerId":12284,"masterFundFlag":1,"status":"normal","exchange":"jj","name":"光大保德信健康优加混合型证券投资基金","fundCollectionId":4000050360000,"currency":"CNY","inceptionDate":"2021-08-04T16:00:00.000Z","followedNum":6,"masterFundShortName":"光大保德信健康优加混合","setUpDate":"2021-08-04T16:00:00.000Z","setUpAssetScale":1766098196.86,"setUpShares":1766098196.86,"pinyin":"gdbdxjkyjhhxzqtzjj","fundCollection":{"exchange":"jjgs","stockType":"fund_collection","stockCode":"50360000","tickerId":50360000,"name":"光大保德信基金管理有限公司"},"managers":[{"name":"朱剑涛","stockType":"fund_manager","stockCode":"j101019652","exchange":"fm","tickerId":261020244630}],"hotMetrics":{"fss":{"stockId":3000000012284,"type":"fss","f_s_s_d":"2024-06-29T16:00:00.000Z","f_ins_h_s_r":0.0322,"f_ins_h_s_r_c_hy":0.0023999999999999994,"f_ins_h_s_r_c_1y":0.0017000000000000001,"f_ind_h_s_r":0.9678,"f_ind_h_s_r_c_hy":-0.0023999999999999577,"f_ind_h_s_r_c_1y":-0.0017000000000000348,"f_h_a":10632,"f_h_s_a":109348,"last_data_date":"2025-06-29T16:00:00.000Z"},"fpr":{"stockId":3000000012284,"type":"fpr","f_p_r_fys_ssc":8961,"f_p_r_fys_ssrp":0.5831473214285714,"f_p_r_m1_ssc":9322,"f_p_r_m1_ssrp":0.08893895504774166,"f_p_r_m3_ssc":9178,"f_p_r_m3_ssrp":0.8198757763975155,"f_p_r_m6_ssc":8961,"f_p_r_m6_ssrp":0.5831473214285714,"f_p_r_y1_ssc":8436,"f_p_r_y1_ssrp":0.8417308832246592,"f_p_r_y2_ssc":7803,"f_p_r_y2_ssrp":0.5949756472699308,"f_p_r_y3_ssc":7019,"f_p_r_y3_ssrp":0.7892561983471075,"f_cagr_p_r_fs_ssc":9280,"f_cagr_p_r_fs_ssrp":0.8999892229766139},"fp":{"stockId":3000000012284,"type":"fp","f_p_r_fys":0.018147208121826797,"f_p_r_m1":0.1378527868387467,"f_p_r_m3":-0.05722679200940084,"f_p_r_m6":0.018147208121826797,"f_p_r_y1":0.009309347087682607,"f_cagr_p_r_fs":-0.043885196194738185,"f_p_r_d1":0.005201958384333016,"f_p_r_y2":0.26565704369774235,"f_p_r_y3":0.04479749967443536,"last_data_date":"2026-07-01T16:00:00.000Z","f_i_d":"2021-08-04T16:00:00.000Z"},"ff":{"stockId":3000000012284,"type":"ff","f_m_f":5706073,"f_m_f_r":0.012,"f_c_f":951012,"f_c_f_r":0.002,"f_m_a_c_f":6657085,"f_m_a_c_f_r":0.014,"f_m_c_f_d":"2024-06-29T16:00:00.000Z","f_c_fr":0.002,"f_fr_d":"2025-06-29T16:00:00.000Z","f_m_fr":0.012,"f_mac_fr":0.014},"f_nlacan":{"stockId":3000000012284,"type":"f_nlacan","f_nv_d":"2026-07-01T16:00:00.000Z","f_nv":0.8023,"f_nv_cr":0.015441083407163658},"f_as":{"stockId":3000000012284,"type":"f_as","f_tas":738166363.627,"f_tas_d":"2026-03-30T16:00:00.000Z"}},"masterSlaveFunds":[{"_id":3000000018076,"name":"光大保德信健康优加混合型证券投资基金","fundSecondLevel":"hybrid","stockType":"fund","areaCode":"cn","market":"a","stockCode":"018076","tickerId":18076,"shortName":"光大保德信健康优加混合C","currency":"CNY","__csrcFundId":9556,"exchange":"jj","lastUpdated":"2025-01-04T00:32:23.662Z","fundCollectionId":4000050360000,"inceptionDate":"2023-03-12T16:00:00.000Z","status":"normal","masterFundFlag":null,"activeFundFlag":null,"classificationFlag":null,"closedEnd":null,"etfFundFlag":null,"feederFundFlag":null,"indexFundFlag":null,"lofFundFlag":null,"pensionTargetFlag":null,"pinyin":"gdbdxjkyjhhxzqtzjj","followedNum":1}],"shareholdings":[{"date":"2026-03-30T16:00:00.000Z","declarationDate":"2026-04-21T16:00:00.000Z","fundId":3000000012284,"stockId":1000000000006990,"holdings":144800,"marketCap":58811533,"netValueRatio":0.0795,"quarterlyChange":0.17287098419173907,"stock":{"exchange":"hk","stockType":"company","stockCode":"06990","tickerId":6990,"name":"科伦博泰生物"}},{"date":"2026-03-30T16:00:00.000Z","declarationDate":"2026-04-21T16:00:00.000Z","fundId":3000000012284,"stockId":1000000000001801,"holdings":619750,"marketCap":46457981,"netValueRatio":0.0628,"quarterlyChange":0.11344262295081897,"stock":{"stockCode":"01801","exchange":"hk","stockType":"company","tickerId":1801,"name":"信达生物"}},{"date":"2026-03-30T16:00:00.000Z","declarationDate":"2026-04-21T16:00:00.000Z","fundId":3000000012284,"stockId":2294,"holdings":654600,"marketCap":40133526,"netValueRatio":0.0542,"quarterlyChange":0.23733602421796118,"stock":{"stockCode":"002294","exchange":"sz","stockType":"company","tickerId":2294,"name":"信立泰"}},{"date":"2026-03-30T16:00:00.000Z","declarationDate":"2026-04-21T16:00:00.000Z","fundId":3000000012284,"stockId":603259,"holdings":399800,"marketCap":39220380,"netValueRatio":0.053,"quarterlyChange":0.08230361871138547,"stock":{"stockCode":"603259","exchange":"sh","stockType":"company","tickerId":603259,"name":"药明康德"}},{"date":"2026-03-30T16:00:00.000Z","declarationDate":"2026-04-21T16:00:00.000Z","fundId":3000000012284,"stockId":688331,"holdings":302102,"marketCap":38901674,"netValueRatio":0.0526,"quarterlyChange":0.6553541586322154,"stock":{"name":"荣昌生物","exchange":"sh","stockType":"company","stockCode":"688331","tickerId":688331}},{"date":"2026-03-30T16:00:00.000Z","declarationDate":"2026-04-21T16:00:00.000Z","fundId":3000000012284,"stockId":688235,"holdings":147264,"marketCap":34399397,"netValueRatio":0.0465,"quarterlyChange":-0.1303425167535377,"stock":{"stockCode":"688235","tickerId":688235,"exchange":"sh","stockType":"company","name":"百济神州"}},{"date":"2026-03-30T16:00:00.000Z","declarationDate":"2026-04-21T16:00:00.000Z","fundId":3000000012284,"stockId":2422,"holdings":754315,"marketCap":26167187,"netValueRatio":0.0354,"quarterlyChange":0.1819420783645651,"stock":{"stockCode":"002422","exchange":"sz","stockType":"company","tickerId":2422,"name":"科伦药业"}},{"date":"2026-03-30T16:00:00.000Z","declarationDate":"2026-04-21T16:00:00.000Z","fundId":3000000012284,"stockId":600276,"holdings":416828,"marketCap":23017242,"netValueRatio":0.0311,"quarterlyChange":-0.07302333389289883,"stock":{"stockCode":"600276","exchange":"sh","stockType":"company","tickerId":600276,"name":"恒瑞医药"}},{"date":"2026-03-30T16:00:00.000Z","declarationDate":"2026-04-21T16:00:00.000Z","fundId":3000000012284,"stockId":688621,"holdings":343922,"marketCap":22072913,"netValueRatio":0.0298,"quarterlyChange":0.03266291230893015,"stock":{"stockCode":"688621","tickerId":688621,"exchange":"sh","stockType":"company","name":"阳光诺和"}},{"date":"2026-03-30T16:00:00.000Z","declarationDate":"2026-04-21T16:00:00.000Z","fundId":3000000012284,"stockId":1000000000009606,"holdings":78800,"marketCap":20525055,"netValueRatio":0.0277,"quarterlyChange":-0.010731052984573997,"stock":{"exchange":"hk","stockType":"company","stockCode":"09606","tickerId":9606,"name":"映恩生物-B"}}],"bondHoldings":[{"_id":"69e8fa691398d7984300219d","date":"2026-03-30T16:00:00.000Z","declarationDate":"2026-04-21T16:00:00.000Z","fundId":3000000012284,"stockCode":"019792","stockName":"25国债19","holdings":402000,"marketCap":40503581,"netValueRatio":0.0547,"lastUpdated":"2026-04-22T16:42:17.984Z"}]},"list":[{"_id":"69e8eb781398d79843fe9301","date":"2026-03-30T16:00:00.000Z","declarationDate":"2026-04-21T16:00:00.000Z","stockId":3000000012284,"sao":"2026年一季度市场整体波动，煤炭、石油石化、综合、公用事业等行业涨幅居前，非银、商贸零售、美护、计算机等行业跌幅居前。申万医药生物行业指数下跌0.9%，我们产品净值（A类）上涨0.82%。 一季度医药行业内部表现分化， 耗材、CXO、原料药、IVD等板块涨幅居前，血制品、医疗设备、疫苗等板块跌幅居前。","lastUpdated":"2026-04-22T15:38:32.130Z","fund":{"_id":3000000012284,"__csrcFundId":9556,"stockCode":"012284","shortName":"光大保德信健康优加混合(012284)","fundSecondLevel":"hybrid","stockType":"fund","areaCode":"cn","market":"a","tickerId":12284,"masterFundFlag":1,"lastUpdated":"2026-04-30T23:14:27.111Z","status":"normal","exchange":"jj","name":"光大保德信健康优加混合型证券投资基金","fundCollectionId":4000050360000,"currency":"CNY","inceptionDate":"2021-08-04T16:00:00.000Z","followedNum":6,"masterFundShortName":"光大保德信健康优加混合","setUpDate":"2021-08-04T16:00:00.000Z","setUpAssetScale":1766098196.86,"setUpShares":1766098196.86,"pinyin":"gdbdxjkyjhhxzqtzjj","managers":[{"stockCode":"j101019652","stockType":"fund_manager","exchange":"fm","tickerId":261020244630,"name":"朱剑涛"}]},"announcement":{"linkText":"光大保德信健康优加混合型证券投资基金2026年第1季度报告","linkUrl":"http://eid.csrc.gov.cn/fund/disclose/instance_show_pdf_id.do?instanceid=1474510","linkType":"PDF","source":"csrc_pdf"}},{"_id":"69aecf337fea5b3eb04f88a0","date":"2025-12-30T16:00:00.000Z","declarationDate":"2026-01-21T16:00:00.000Z","stockId":3000000012284,"sao":"2025年四季度市场整体震荡，有色金属、石油石化、通信、军工等行业涨幅居前，医药、地产、美护、计算机等行业跌幅居前。申万医药生物行业指数下跌9.25%，我们产品净值（A类）下跌17.25%。 四季度医药行业内部表现分化， CXO、生物制品、医疗设备、血制品、化学制剂等板块跌幅居前，医药流通板块涨幅居前。","lastUpdated":"2026-03-09T13:46:27.355Z","fund":{"_id":3000000012284,"__csrcFundId":9556,"stockCode":"012284","shortName":"光大保德信健康优加混合(012284)","fundSecondLevel":"hybrid","stockType":"fund","areaCode":"cn","market":"a","tickerId":12284,"masterFundFlag":1,"lastUpdated":"2026-04-30T23:14:27.111Z","status":"normal","exchange":"jj","name":"光大保德信健康优加混合型证券投资基金","fundCollectionId":4000050360000,"currency":"CNY","inceptionDate":"2021-08-04T16:00:00.000Z","followedNum":6,"masterFundShortName":"光大保德信健康优加混合","setUpDate":"2021-08-04T16:00:00.000Z","setUpAssetScale":1766098196.86,"setUpShares":1766098196.86,"pinyin":"gdbdxjkyjhhxzqtzjj","managers":[{"stockCode":"j101019652","stockType":"fund_manager","exchange":"fm","tickerId":261020244630,"name":"朱剑涛"}]},"announcement":{"linkText":"光大保德信健康优加混合型证券投资基金2025年年度报告","linkUrl":"http://eid.csrc.gov.cn/fund/disclose/instance_show_pdf_id.do?instanceid=1454102","linkType":"PDF","source":"csrc_pdf"}},{"_id":"69aecf337fea5b3eb04f889f","date":"2025-09-29T16:00:00.000Z","declarationDate":"2025-10-27T16:00:00.000Z","stockId":3000000012284,"sao":"2025年三季度市场整体上涨，通信、电子、电力设备、有色金属等行业涨幅居前，银行、交运、石油石化、公用事业等行业涨幅居后。申万医药生物行业指数上涨14.9%，我们产品净值（A类）上涨22.22%。 三季度医药行业内部表现分化， CXO、生物制品、医疗耗材、化学制剂等板块涨幅居前，线下药店、血制品、医药流通、中药等板块跌幅居前。","lastUpdated":"2026-03-09T13:46:27.352Z","fund":{"_id":3000000012284,"__csrcFundId":9556,"stockCode":"012284","shortName":"光大保德信健康优加混合(012284)","fundSecondLevel":"hybrid","stockType":"fund","areaCode":"cn","market":"a","tickerId":12284,"masterFundFlag":1,"lastUpdated":"2026-04-30T23:14:27.111Z","status":"normal","exchange":"jj","name":"光大保德信健康优加混合型证券投资基金","fundCollectionId":4000050360000,"currency":"CNY","inceptionDate":"2021-08-04T16:00:00.000Z","followedNum":6,"masterFundShortName":"光大保德信健康优加混合","setUpDate":"2021-08-04T16:00:00.000Z","setUpAssetScale":1766098196.86,"setUpShares":1766098196.86,"pinyin":"gdbdxjkyjhhxzqtzjj","managers":[{"stockCode":"j101019652","stockType":"fund_manager","exchange":"fm","tickerId":261020244630,"name":"朱剑涛"}]},"announcement":{"linkText":"光大保德信健康优加混合型证券投资基金2025年第3季度报告","linkUrl":"http://eid.csrc.gov.cn/fund/disclose/instance_show_pdf_id.do?instanceid=1374069","linkType":"PDF","source":"csrc_pdf"}},{"_id":"69aecf337fea5b3eb04f889e","date":"2025-06-29T16:00:00.000Z","stockId":3000000012284,"sao":"2025年上半年市场整体上涨，有色、银行、军工、传媒、通信等行业涨幅居前，煤炭、食品饮料、地产、石油石化等行业跌幅居前。申万医药生物行业指数上涨7.36%，我们产品净值（A类）上涨25.5%。 上半年医药行业内部表现分化，化学制剂、CXO、原料药、生物制品、线下药店等板块涨幅居前，疫苗、中药、医药流通、血制品等板块跌幅居前。","declarationDate":"2025-07-20T16:00:00.000Z","lastUpdated":"2026-03-09T13:46:27.349Z","mo":"2025年上半年经济整体运行稳中有进，高质量发展取得新成效。6月制造业PMI为49.7%，较前值回升0.2个百分点.非制造业PMI回升0.2个百分点至50.5%，其中服务业PMI回落0.1个百分点、建筑业PMI回升1.8个百分点。整体看，PMI数据连续2个月上升，国内经济保持修复态势。5月全国规模以上工业增加值同比增长5.8%，其中装备制造业增加值同比增长9.0%，高技术制造业增加值增长8.6%。中游行业生产仍保持较高水平，上游以及下游行业整体上工业生产边际基本持平。1-5月份，全国固定资产投资（不含农户）191947亿元，同比增长3.7%；扣除房地产开发投资，全国固定资产投资增长7.7%。社会消费品零售总额同比增长6.4%；环比增长0.9%，环比边际呈加速态势，消费潜力得到进一步释放。从细分商品来看，受补贴拉动的品类销售金额同比增长明显，例如体育娱乐用品、家用电器和音像器材、家具、通讯器材单月同比增速达到28.3%、53%、25.6%、33%。汽车销售仍面临一定压力，单月同比1.1%，累计同比-0.1%。上半年医药整体表现较好，创新药表现尤为突出。我们继续看好国内创新药产业发展，政策端，国家支持创新药发展的产业政策持续推进，各地细化政策不断落地；研发端，国内创新药企业向海外药企的授权不断落地，彰显本土企业研发实力；盈利端，国内创新药品种销售收入持续超预期，创新药企业逐步开始实现盈利，企业自身开始实现正循环。下半年我们会在均衡成长的方向上继续调整完善组合，买入基本面好、稳定性强、估值相对较低的公司。","fund":{"_id":3000000012284,"__csrcFundId":9556,"stockCode":"012284","shortName":"光大保德信健康优加混合(012284)","fundSecondLevel":"hybrid","stockType":"fund","areaCode":"cn","market":"a","tickerId":12284,"masterFundFlag":1,"lastUpdated":"2026-04-30T23:14:27.111Z","status":"normal","exchange":"jj","name":"光大保德信健康优加混合型证券投资基金","fundCollectionId":4000050360000,"currency":"CNY","inceptionDate":"2021-08-04T16:00:00.000Z","followedNum":6,"masterFundShortName":"光大保德信健康优加混合","setUpDate":"2021-08-04T16:00:00.000Z","setUpAssetScale":1766098196.86,"setUpShares":1766098196.86,"pinyin":"gdbdxjkyjhhxzqtzjj","managers":[{"stockCode":"j101019652","stockType":"fund_manager","exchange":"fm","tickerId":261020244630,"name":"朱剑涛"}]},"announcement":{"linkText":"光大保德信健康优加混合型证券投资基金2025年中期报告","linkUrl":"http://eid.csrc.gov.cn/fund/disclose/instance_show_pdf_id.do?instanceid=1341920","linkType":"PDF","source":"csrc_pdf"}},{"_id":"69aecf337fea5b3eb04f889d","date":"2025-03-30T16:00:00.000Z","stockId":3000000012284,"sao":"2025年一季度市场整体上涨，有色、汽车、机械、计算机等行业涨幅居前，煤炭、商贸零售、石油石化、建筑装饰、房地产等行业跌幅居前。申万医药生物行业指数上涨2.29%，我们产品净值（A类）上涨8.75%。 一季度医药行业内部表现分化，CXO、化学制剂、生物制品、原料药等板块涨幅居前，疫苗、中药、血制品、医药流通等板块跌幅较大。","declarationDate":"2025-04-21T16:00:00.000Z","lastUpdated":"2026-03-09T13:46:27.341Z","fund":{"_id":3000000012284,"__csrcFundId":9556,"stockCode":"012284","shortName":"光大保德信健康优加混合(012284)","fundSecondLevel":"hybrid","stockType":"fund","areaCode":"cn","market":"a","tickerId":12284,"masterFundFlag":1,"lastUpdated":"2026-04-30T23:14:27.111Z","status":"normal","exchange":"jj","name":"光大保德信健康优加混合型证券投资基金","fundCollectionId":4000050360000,"currency":"CNY","inceptionDate":"2021-08-04T16:00:00.000Z","followedNum":6,"masterFundShortName":"光大保德信健康优加混合","setUpDate":"2021-08-04T16:00:00.000Z","setUpAssetScale":1766098196.86,"setUpShares":1766098196.86,"pinyin":"gdbdxjkyjhhxzqtzjj","managers":[{"stockCode":"j101019652","stockType":"fund_manager","exchange":"fm","tickerId":261020244630,"name":"朱剑涛"}]},"announcement":{"linkText":"光大保德信健康优加混合型证券投资基金2025年第1季度报告","linkUrl":"http://eid.csrc.gov.cn/fund/disclose/instance_show_pdf_id.do?instanceid=1272603","linkType":"PDF","source":"csrc_pdf"}},{"_id":"69aecf337fea5b3eb04f889c","date":"2024-12-30T16:00:00.000Z","stockId":3000000012284,"sao":"2024年市场整体上涨，银行、非银金融、通信、家电、电子、汽车等行业涨幅居前，医药、农林牧渔、美护、食品饮料等行业跌幅居前。申万医药生物行业指数下跌14.33%，跌幅第一。2024年医药行业内部表现分化，医药流通、化学制剂、原料药、中药等板块跌幅较小，疫苗、线下药店、CXO、生物制品、医院等板块跌幅较大。我们持仓相对均衡，2024年度净值下跌15.11%（A 类）、15.14%（C 类），表现一般。","declarationDate":"2025-01-21T16:00:00.000Z","lastUpdated":"2026-03-09T13:46:27.339Z","mo":"2024年整体经济表现一定韧性。全国规模以上工业增加值比上年增长5.8%。其中，采矿业增加值增长3.1%，制造业增长6.1%，电力、热力、燃气及水生产和供应业增长5.3%。装备制造业增加值增长7.7%，高技术制造业增加值增长8.9%，中游制造业表现较好。2024年全国固定资产投资514374亿元，比上年增长3.2%；扣除房地产开发投资，全国固定资产投资增长7.2%。全年社会消费品零售总额487895亿元，比上年增长3.5%。按经营单位所在地分，城镇消费品零售额421166亿元，增长3.4%；乡村消费品零售额66729亿元，增长4.3%。全年全国居民人均可支配收入41314元，比上年名义增长5.3%，扣除价格因素实际增长5.1%。四季度全国居民人均可支配收入以及消费支出同比增速分别为5.6%和4.5%，边际均有回升。2024年医药表现较弱，2025年我们相对看好创新药及院内用药，同时关注AI在医药产业的进展和应用。买入一些相对估值较低、基本面较好的公司，按照我们一贯坚持的均衡成长的方向不断完善组合。","fund":{"_id":3000000012284,"__csrcFundId":9556,"stockCode":"012284","shortName":"光大保德信健康优加混合(012284)","fundSecondLevel":"hybrid","stockType":"fund","areaCode":"cn","market":"a","tickerId":12284,"masterFundFlag":1,"lastUpdated":"2026-04-30T23:14:27.111Z","status":"normal","exchange":"jj","name":"光大保德信健康优加混合型证券投资基金","fundCollectionId":4000050360000,"currency":"CNY","inceptionDate":"2021-08-04T16:00:00.000Z","followedNum":6,"masterFundShortName":"光大保德信健康优加混合","setUpDate":"2021-08-04T16:00:00.000Z","setUpAssetScale":1766098196.86,"setUpShares":1766098196.86,"pinyin":"gdbdxjkyjhhxzqtzjj","managers":[{"stockCode":"j101019652","stockType":"fund_manager","exchange":"fm","tickerId":261020244630,"name":"朱剑涛"}]},"announcement":{"linkText":"光大保德信健康优加混合型证券投资基金2024年年度报告","linkUrl":"http://eid.csrc.gov.cn/fund/disclose/instance_show_pdf_id.do?instanceid=1253830","linkType":"PDF","source":"csrc_pdf"}},{"_id":"69aecf337fea5b3eb04f889b","date":"2024-09-29T16:00:00.000Z","stockId":3000000012284,"sao":"2024年三季度市场波动较大，非银、地产、综合、商贸零售、社服等行业表现较好，煤炭、石油石化、公用事业、农林牧渔等行业表现较弱。申万医药行业上半年上涨17.62%，我们在三季度净值上涨9.51%（A类）、9.47%（C类），表现一般。三季度医药行业内部表现相对分化，医院、CXO、疫苗等前期跌幅大的板块表现较好，血制品、药店、医疗设备、中药等表现较弱。","declarationDate":"2024-10-24T16:00:00.000Z","lastUpdated":"2026-03-09T13:46:27.335Z","fund":{"_id":3000000012284,"__csrcFundId":9556,"stockCode":"012284","shortName":"光大保德信健康优加混合(012284)","fundSecondLevel":"hybrid","stockType":"fund","areaCode":"cn","market":"a","tickerId":12284,"masterFundFlag":1,"lastUpdated":"2026-04-30T23:14:27.111Z","status":"normal","exchange":"jj","name":"光大保德信健康优加混合型证券投资基金","fundCollectionId":4000050360000,"currency":"CNY","inceptionDate":"2021-08-04T16:00:00.000Z","followedNum":6,"masterFundShortName":"光大保德信健康优加混合","setUpDate":"2021-08-04T16:00:00.000Z","setUpAssetScale":1766098196.86,"setUpShares":1766098196.86,"pinyin":"gdbdxjkyjhhxzqtzjj","managers":[{"stockCode":"j101019652","stockType":"fund_manager","exchange":"fm","tickerId":261020244630,"name":"朱剑涛"}]},"announcement":{"linkText":"光大保德信健康优加混合型证券投资基金2024年第3季度报告","linkUrl":"http://eid.csrc.gov.cn/fund/disclose/instance_show_pdf_id.do?instanceid=1175795","linkType":"PDF","source":"csrc_pdf"}},{"_id":"69aecf337fea5b3eb04f889a","date":"2024-06-29T16:00:00.000Z","stockId":3000000012284,"sao":"2024年上半年市场表现较为分化，银行、煤炭、公用事业、家电、石油石化等行业表现较好，综合、计算机、商贸零售、社服、传媒、医药等行业表现较弱。申万医药行业上半年下跌21.09%，表现较弱，我们在上半年净值下跌13.02%（A类）、12.92%（C类）。上半年医药行业内部表现相对分化，血制品、医药流通、中药、原料药等板块表现较好，疫苗、CXO、医院、线下药店等表现较弱。我们整体持仓结构相对均衡，因此表现相对略好于申万医药指数，但弱于业绩比较基准。","declarationDate":"2024-07-18T16:00:00.000Z","lastUpdated":"2026-03-09T13:46:27.333Z","mo":"2024年上半年整体经济增速较好，GDP增速5.0%。上半年，全国规模以上工业增加值同比增长6.0%；全国固定资产投资同比增长3.9%；其中扣除房地产开发投资，全国固定资产投资增长8.5%。社会消费品零售总额同比增长3.7%，其中城镇消费品零售额增长3.6%，乡村消费品零售额增长4.5%。6月CPI同比0.2%，前值0.3%；核心CPI同比0.6%，CPI环比-0.2%。6月PPI同比-0.8%，前值-1.4%，PPI环比0.2%。6月制造业采购经理指数（PMI）为49.5%，与上月持平，制造业景气度基本稳定。6月非制造业商务活动指数为50.5%，比上月下降0.6个百分点，高于临界点，非制造业继续保持扩张。中国6月出口（以美元计价）同比8.6%，前值7.6%；进口-2.3%，前值1.8%；贸易差额990.5亿美元。2024年上半年医药表现相对较弱，未来我们继续看好创新药及院内用药，市场对业绩的确定性要求在不断提高。投资方向上，我们会持续关注一些相对估值较低、基本面较好的公司，按照我们一贯坚持的均衡成长的方向不断完善组合。","fund":{"_id":3000000012284,"__csrcFundId":9556,"stockCode":"012284","shortName":"光大保德信健康优加混合(012284)","fundSecondLevel":"hybrid","stockType":"fund","areaCode":"cn","market":"a","tickerId":12284,"masterFundFlag":1,"lastUpdated":"2026-04-30T23:14:27.111Z","status":"normal","exchange":"jj","name":"光大保德信健康优加混合型证券投资基金","fundCollectionId":4000050360000,"currency":"CNY","inceptionDate":"2021-08-04T16:00:00.000Z","followedNum":6,"masterFundShortName":"光大保德信健康优加混合","setUpDate":"2021-08-04T16:00:00.000Z","setUpAssetScale":1766098196.86,"setUpShares":1766098196.86,"pinyin":"gdbdxjkyjhhxzqtzjj","managers":[{"stockCode":"j101019652","stockType":"fund_manager","exchange":"fm","tickerId":261020244630,"name":"朱剑涛"}]},"announcement":{"linkText":"光大保德信健康优加混合型证券投资基金2024年中期报告","linkUrl":"http://eid.csrc.gov.cn/fund/disclose/instance_show_pdf_id.do?instanceid=1147666","linkType":"PDF","source":"csrc_pdf"}},{"_id":"69aecf337fea5b3eb04f8899","date":"2024-03-30T16:00:00.000Z","stockId":3000000012284,"sao":"2024年一季度市场表现较为分化，银行、石油石化、煤炭、家电等行业表现较好，医药、计算机、电子等行业表现较弱。申万医药行业一季度下跌12.08%，表现较弱。一季度医药行业内部表现相对分化，流通、中药、药店等板块表现较好，医疗研发外包、疫苗、医院等表现较弱。我们整体持仓结构相对均衡，中药板块持仓比例相对较高，因此表现相对较好。","declarationDate":"2024-04-21T16:00:00.000Z","lastUpdated":"2026-03-09T13:46:27.330Z","fund":{"_id":3000000012284,"__csrcFundId":9556,"stockCode":"012284","shortName":"光大保德信健康优加混合(012284)","fundSecondLevel":"hybrid","stockType":"fund","areaCode":"cn","market":"a","tickerId":12284,"masterFundFlag":1,"lastUpdated":"2026-04-30T23:14:27.111Z","status":"normal","exchange":"jj","name":"光大保德信健康优加混合型证券投资基金","fundCollectionId":4000050360000,"currency":"CNY","inceptionDate":"2021-08-04T16:00:00.000Z","followedNum":6,"masterFundShortName":"光大保德信健康优加混合","setUpDate":"2021-08-04T16:00:00.000Z","setUpAssetScale":1766098196.86,"setUpShares":1766098196.86,"pinyin":"gdbdxjkyjhhxzqtzjj","managers":[{"stockCode":"j101019652","stockType":"fund_manager","exchange":"fm","tickerId":261020244630,"name":"朱剑涛"}]},"announcement":{"linkText":"光大保德信健康优加混合型证券投资基金2024年第1季度报告","linkUrl":"http://eid.csrc.gov.cn/fund/disclose/instance_show_pdf_id.do?instanceid=1073629","linkType":"PDF","source":"csrc_pdf"}},{"_id":"69aecf337fea5b3eb04f8898","date":"2023-12-30T16:00:00.000Z","stockId":3000000012284,"sao":"2023年市场表现较为分化，通信、传媒、计算机、电子、石油石化、煤炭等行业表现较好，美护、商贸零售、地产、电力设备、建材等行业表现较弱。申万医药行业2023年度下跌7.05%，表现一般。我们在2023年度净值下跌7.64%，表现和指数相符。2023年度医药行业内部也是表现分化，血制品、化学制剂、中药等板块表现较好，医院、医疗研发外包、药店、疫苗等表现较弱。我们整体持仓结构相对均衡，小市值个股持仓较少，因此整体表现和行业指数差不多。","declarationDate":"2024-01-21T16:00:00.000Z","lastUpdated":"2026-03-09T13:46:27.325Z","mo":"2023年12月制造业采购经理指数（PMI）为49%，比上月下降0.4个百分点，制造业景气水平有所回落。非制造业商务活动指数为50.4%，比上月上升0.2个百分点，高于临界点，非制造业扩张有所加快。2024年1月新增社融6.5万亿，同比多增5000亿。新增人民币信贷4.9万亿，同比持平。M2同比8.7%，前值9.7%；M1同比5.9%，前值1.3%。整体来看，社融总量略超预期，结构改善，居民信贷改善，M1明显修复。2024年市场可能会继续演绎结构化行情，医药行业作为刚需行业，在中国老龄化进程中的需求韧性强，供给上伴随中国科研实力的提高，越来越多国产创新药上市销售能够更好地满足临床所需，我们长期看好中国医药行业的发展及投资机会。投资方向上，我们会坚持选择产品好、渠道强、管理高效的公司进行投资，此外我们也会兼顾估值与业绩增速的匹配度来选股，按照我们一贯坚持的均衡成长的方向不断完善组合。","fund":{"_id":3000000012284,"__csrcFundId":9556,"stockCode":"012284","shortName":"光大保德信健康优加混合(012284)","fundSecondLevel":"hybrid","stockType":"fund","areaCode":"cn","market":"a","tickerId":12284,"masterFundFlag":1,"lastUpdated":"2026-04-30T23:14:27.111Z","status":"normal","exchange":"jj","name":"光大保德信健康优加混合型证券投资基金","fundCollectionId":4000050360000,"currency":"CNY","inceptionDate":"2021-08-04T16:00:00.000Z","followedNum":6,"masterFundShortName":"光大保德信健康优加混合","setUpDate":"2021-08-04T16:00:00.000Z","setUpAssetScale":1766098196.86,"setUpShares":1766098196.86,"pinyin":"gdbdxjkyjhhxzqtzjj","managers":[{"stockCode":"j101019652","stockType":"fund_manager","exchange":"fm","tickerId":261020244630,"name":"朱剑涛"}]},"announcement":{"linkText":"光大保德信健康优加混合型证券投资基金2023年年度报告","linkUrl":"http://eid.csrc.gov.cn/fund/disclose/instance_show_pdf_id.do?instanceid=1054006","linkType":"PDF","source":"csrc_pdf"}},{"_id":"69aecf337fea5b3eb04f8897","date":"2023-09-29T16:00:00.000Z","stockId":3000000012284,"sao":"2023年三季度市场表现较为分化，非银、煤炭、石油石化、钢铁、银行等行业表现较好，电力设备、传媒、计算机、通信、军工等行业表现较弱。申万医药行业三季度下跌1.57%，表现中等偏上。我们在三季度净值下跌4.10%，表现弱于指数。三季度医药研发外包板块表现突出，我们整体持仓结构相对均衡，CXO板块持仓比例相对较低，因此表现一般。","declarationDate":"2023-10-24T16:00:00.000Z","lastUpdated":"2026-03-09T13:46:27.322Z","fund":{"_id":3000000012284,"__csrcFundId":9556,"stockCode":"012284","shortName":"光大保德信健康优加混合(012284)","fundSecondLevel":"hybrid","stockType":"fund","areaCode":"cn","market":"a","tickerId":12284,"masterFundFlag":1,"lastUpdated":"2026-04-30T23:14:27.111Z","status":"normal","exchange":"jj","name":"光大保德信健康优加混合型证券投资基金","fundCollectionId":4000050360000,"currency":"CNY","inceptionDate":"2021-08-04T16:00:00.000Z","followedNum":6,"masterFundShortName":"光大保德信健康优加混合","setUpDate":"2021-08-04T16:00:00.000Z","setUpAssetScale":1766098196.86,"setUpShares":1766098196.86,"pinyin":"gdbdxjkyjhhxzqtzjj","managers":[{"stockCode":"j101019652","stockType":"fund_manager","exchange":"fm","tickerId":261020244630,"name":"朱剑涛"}]},"announcement":{"linkText":"光大保德信健康优加混合型证券投资基金2023年第3季度报告","linkUrl":"http://eid.csrc.gov.cn/fund/disclose/instance_show_pdf_id.do?instanceid=987805","linkType":"PDF","source":"csrc_pdf"}},{"_id":"69aecf337fea5b3eb04f8896","date":"2023-06-29T16:00:00.000Z","stockId":3000000012284,"sao":"2023上半年市场表现较为分化，通信、传媒、计算机、机械设备等行业表现较好，商贸零售、房地产、美容护理等行业表现较弱。申万医药行业上半年下跌5.56%，表现相对较弱。我们在上半年净值下跌3.03%，表现优于指数。我们整体持仓相对看重公司业绩增速和股票估值的匹配度，结构相对均衡，在波动较大的市场行情中，表现相对较好。","declarationDate":"2023-07-20T16:00:00.000Z","lastUpdated":"2026-03-09T13:46:27.320Z","mo":"1--6月份，全国规模以上工业企业实现利润总额33884.6亿元，同比下降16.8%，降幅比1--5月份收窄2.0个百分点。工业企业利润6月单月同比-13.2%，前值-18.7%。6月规模以上工业企业营收降幅边际收窄，成本下降幅度边际扩大，利润降幅边际有收窄。利润增速连续两月边际改善，7月全国制造业PMI为49.3%，比上月上升0.3个百分点，制造业景气水平有所改善。7月非制造业商务活动指数为51.5%，比上月下降1.7个百分点，仍高于临界点，非制造业今年以来始终保持扩张态势。2023年三季度市场可能会继续演绎结构化行情，前期调整幅度较大的板块相对投资机会更多。投资方向上，我们会买入一些相对估值较低、基本面较好的公司，按照我们一贯坚持的均衡成长的方向不断完善组合。","fund":{"_id":3000000012284,"__csrcFundId":9556,"stockCode":"012284","shortName":"光大保德信健康优加混合(012284)","fundSecondLevel":"hybrid","stockType":"fund","areaCode":"cn","market":"a","tickerId":12284,"masterFundFlag":1,"lastUpdated":"2026-04-30T23:14:27.111Z","status":"normal","exchange":"jj","name":"光大保德信健康优加混合型证券投资基金","fundCollectionId":4000050360000,"currency":"CNY","inceptionDate":"2021-08-04T16:00:00.000Z","followedNum":6,"masterFundShortName":"光大保德信健康优加混合","setUpDate":"2021-08-04T16:00:00.000Z","setUpAssetScale":1766098196.86,"setUpShares":1766098196.86,"pinyin":"gdbdxjkyjhhxzqtzjj","managers":[{"stockCode":"j101019652","stockType":"fund_manager","exchange":"fm","tickerId":261020244630,"name":"朱剑涛"}]},"announcement":{"linkText":"光大保德信健康优加混合型证券投资基金2023年中期报告","linkUrl":"http://eid.csrc.gov.cn/fund/disclose/instance_show_pdf_id.do?instanceid=963583","linkType":"PDF","source":"csrc_pdf"}},{"_id":"69aecf337fea5b3eb04f8895","date":"2023-03-30T16:00:00.000Z","stockId":3000000012284,"sao":"2023一季度市场整体表现较好，计算机、传媒、通信、电子等行业表现较好，地产、商贸零售、银行等行业表现较弱。申万医药行业一季度上涨1.86%，表现相对较弱。我们在一季度净值下跌0.3%，表现不及指数。我们整体持仓还是坚持结构相对均衡，在分化相对严重的行情中，组合内部会有对冲，因此净值表现一般。","declarationDate":"2023-04-20T16:00:00.000Z","lastUpdated":"2026-03-09T13:46:27.317Z","fund":{"_id":3000000012284,"__csrcFundId":9556,"stockCode":"012284","shortName":"光大保德信健康优加混合(012284)","fundSecondLevel":"hybrid","stockType":"fund","areaCode":"cn","market":"a","tickerId":12284,"masterFundFlag":1,"lastUpdated":"2026-04-30T23:14:27.111Z","status":"normal","exchange":"jj","name":"光大保德信健康优加混合型证券投资基金","fundCollectionId":4000050360000,"currency":"CNY","inceptionDate":"2021-08-04T16:00:00.000Z","followedNum":6,"masterFundShortName":"光大保德信健康优加混合","setUpDate":"2021-08-04T16:00:00.000Z","setUpAssetScale":1766098196.86,"setUpShares":1766098196.86,"pinyin":"gdbdxjkyjhhxzqtzjj","managers":[{"stockCode":"j101019652","stockType":"fund_manager","exchange":"fm","tickerId":261020244630,"name":"朱剑涛"}]},"announcement":{"linkText":"光大保德信健康优加混合型证券投资基金2023年第1季度报告","linkUrl":"http://eid.csrc.gov.cn/fund/disclose/instance_show_pdf_id.do?instanceid=881558","linkType":"PDF","source":"csrc_pdf"}},{"_id":"69aecf337fea5b3eb04f8894","date":"2022-12-30T16:00:00.000Z","stockId":3000000012284,"sao":"2022年市场整体表现偏弱，全部A股下跌8.08%，沪深300下跌11.65%，创业板下跌20.99%。申万行业分类中表现相对较好的是采掘和综合，表现相对较差的是电子、建材和传媒。申万医药行业指数下跌20.33%，健康优加基金净值22年下跌18.42%，整体表现较好。22年我们的投资组合中加大了中药股的比重，中医药是国家政策重点支持的方向，我们选择了一些业绩增速与估值相比具备较高优势的公司重仓持有，整体对基金业绩贡献较大。2023年我们会继续选择高性价比的公司，按照一直坚持的均衡成长的方向不断完善组合。","declarationDate":"2023-01-19T16:00:00.000Z","lastUpdated":"2026-03-09T13:46:27.314Z","mo":"12月全国制造业PMI为47.0%，比上月下降1.0个百分点。1-11月中国规模以上工业企业利润总额77179.6亿元，同比下降3.6%。11月社会消费品零售总额同比降5.9%，前值降0.5%。国内经济整体处在逐步恢复过程之中，23年的经济恢复依然值得期待。2023年市场整体震荡向上的概率较大，前期调整幅度较大的板块相对投资机会更多。投资方向上，我们看好商业化逐渐落地的创新药企业；看好政策持续支持的中医中药公司释放业绩的潜能；看好医疗新基建大背景下相关医疗设备及器械公司的放量；看好经济恢复带来的医疗服务及消费等相关领域的高增长；看好前期调整较多，部分风险因素释放，有望估值修复的CXO板块。总而言之，医药赛道上具备投资机会的方向很多，我们将继续做好公司的深度研究和比较，构建更好的投资组合。","fund":{"_id":3000000012284,"__csrcFundId":9556,"stockCode":"012284","shortName":"光大保德信健康优加混合(012284)","fundSecondLevel":"hybrid","stockType":"fund","areaCode":"cn","market":"a","tickerId":12284,"masterFundFlag":1,"lastUpdated":"2026-04-30T23:14:27.111Z","status":"normal","exchange":"jj","name":"光大保德信健康优加混合型证券投资基金","fundCollectionId":4000050360000,"currency":"CNY","inceptionDate":"2021-08-04T16:00:00.000Z","followedNum":6,"masterFundShortName":"光大保德信健康优加混合","setUpDate":"2021-08-04T16:00:00.000Z","setUpAssetScale":1766098196.86,"setUpShares":1766098196.86,"pinyin":"gdbdxjkyjhhxzqtzjj","managers":[{"stockCode":"j101019652","stockType":"fund_manager","exchange":"fm","tickerId":261020244630,"name":"朱剑涛"}]},"announcement":{"linkText":"光大保德信健康优加混合型证券投资基金2022年年度报告","linkUrl":"http://eid.csrc.gov.cn/fund/disclose/instance_show_pdf_id.do?instanceid=871020","linkType":"PDF","source":"csrc_pdf"}},{"_id":"69aecf337fea5b3eb04f8893","date":"2022-09-29T16:00:00.000Z","stockId":3000000012284,"sao":"2022三季度市场整体偏弱，采掘、通信、公用事业等行业表现较好，建材、钢铁、休闲服务等行业表现较弱。申万医药行业三季度下跌12.88%，表现较弱。尤其是机构持仓比例相对较高的一些个股回调幅度较大，因此医药基金整体表现一般。我们在三季度净值下跌幅度也很大，还是坚持买入一些相对估值较低、基本面较好的公司，按照我们一贯坚持的均衡成长的方向不断完善组合。","declarationDate":"2022-10-25T16:00:00.000Z","lastUpdated":"2026-03-09T13:46:27.312Z","fund":{"_id":3000000012284,"__csrcFundId":9556,"stockCode":"012284","shortName":"光大保德信健康优加混合(012284)","fundSecondLevel":"hybrid","stockType":"fund","areaCode":"cn","market":"a","tickerId":12284,"masterFundFlag":1,"lastUpdated":"2026-04-30T23:14:27.111Z","status":"normal","exchange":"jj","name":"光大保德信健康优加混合型证券投资基金","fundCollectionId":4000050360000,"currency":"CNY","inceptionDate":"2021-08-04T16:00:00.000Z","followedNum":6,"masterFundShortName":"光大保德信健康优加混合","setUpDate":"2021-08-04T16:00:00.000Z","setUpAssetScale":1766098196.86,"setUpShares":1766098196.86,"pinyin":"gdbdxjkyjhhxzqtzjj","managers":[{"stockCode":"j101019652","stockType":"fund_manager","exchange":"fm","tickerId":261020244630,"name":"朱剑涛"}]},"announcement":{"linkText":"光大保德信健康优加混合型证券投资基金2022年第3季度报告","linkUrl":"http://eid.csrc.gov.cn/fund/disclose/instance_show_pdf_id.do?instanceid=806157","linkType":"PDF","source":"csrc_pdf"}},{"_id":"69aecf337fea5b3eb04f8892","date":"2022-06-29T16:00:00.000Z","stockId":3000000012284,"sao":"2022上半年市场整体表现较弱，只有煤炭行业为正收益，上涨31.38%。申万医药行业上半年下跌14.24%，表现较弱。尤其是机构持仓比例相对较高的一些个股回调幅度较大，因此医药基金整体表现一般。我们基金净值在上半年下跌11.39%，主要是布局了一些相对估值较低、基本面较好的公司，表现相对较好。二季度市场整体回撤时，因仓位没有及时调整，回撤幅度较大，未来我们将继续按照一贯坚持的均衡成长的方向不断完善组合。","declarationDate":"2022-07-20T16:00:00.000Z","lastUpdated":"2026-03-09T13:46:27.309Z","mo":"6月出口同比17.9%，高于前值的16.9%；工业增加值同比3.9%，高于前值的0.7%；服务业生产指数同比1.3%，高于前值的-5.1%；固定资产投资同比5.6%，高于前值的4.6%；社会消费品零售总额同比3.1%，高于前值的-6.7%。地产销售同比-18.3%，高于前值的-31.8%。6月制造业PMI指数为50.2，非制造业PMI54.7，分别较5月上升0.6个和6.9个百分点，在连续三个月收缩后重回荣枯线之上，说明企业生产经营活动恢复加快。二季度GDP同比增长0.4%，略低预期，预计下半年支持经济的政策仍会继续，全年稳增长的经济指标依然值得期待。2022年三季度市场在前期反弹的基础上可能会是震荡行情，外部因素或仍会影响市场。投资方向上，我们买入了一些前期调整幅度较大，业绩较好的行业及个股，后续我们会继续致力于挖掘一些业绩超预期的个股。","fund":{"_id":3000000012284,"__csrcFundId":9556,"stockCode":"012284","shortName":"光大保德信健康优加混合(012284)","fundSecondLevel":"hybrid","stockType":"fund","areaCode":"cn","market":"a","tickerId":12284,"masterFundFlag":1,"lastUpdated":"2026-04-30T23:14:27.111Z","status":"normal","exchange":"jj","name":"光大保德信健康优加混合型证券投资基金","fundCollectionId":4000050360000,"currency":"CNY","inceptionDate":"2021-08-04T16:00:00.000Z","followedNum":6,"masterFundShortName":"光大保德信健康优加混合","setUpDate":"2021-08-04T16:00:00.000Z","setUpAssetScale":1766098196.86,"setUpShares":1766098196.86,"pinyin":"gdbdxjkyjhhxzqtzjj","managers":[{"stockCode":"j101019652","stockType":"fund_manager","exchange":"fm","tickerId":261020244630,"name":"朱剑涛"}]},"announcement":{"linkText":"光大保德信健康优加混合型证券投资基金2022年中期报告","linkUrl":"http://eid.csrc.gov.cn/fund/disclose/instance_show_pdf_id.do?instanceid=785444","linkType":"PDF","source":"csrc_pdf"}},{"_id":"69aecf337fea5b3eb04f8891","date":"2022-03-30T16:00:00.000Z","stockId":3000000012284,"sao":"2022一季度市场整体震荡下行，采掘、地产、建筑等行业表现较好，电子、军工、汽车等行业表现较弱。申万医药行业一季度下跌5.25%，表现一般。尤其是机构持仓比例相对较高的一些个股回调幅度较大，因此医药基金整体表现一般。我们在一季度布局了一些相对估值较低、基本面较好的公司，按照我们一贯坚持的均衡成长的方向不断完善组合。","declarationDate":"2022-04-21T16:00:00.000Z","lastUpdated":"2026-03-09T13:46:27.306Z","fund":{"_id":3000000012284,"__csrcFundId":9556,"stockCode":"012284","shortName":"光大保德信健康优加混合(012284)","fundSecondLevel":"hybrid","stockType":"fund","areaCode":"cn","market":"a","tickerId":12284,"masterFundFlag":1,"lastUpdated":"2026-04-30T23:14:27.111Z","status":"normal","exchange":"jj","name":"光大保德信健康优加混合型证券投资基金","fundCollectionId":4000050360000,"currency":"CNY","inceptionDate":"2021-08-04T16:00:00.000Z","followedNum":6,"masterFundShortName":"光大保德信健康优加混合","setUpDate":"2021-08-04T16:00:00.000Z","setUpAssetScale":1766098196.86,"setUpShares":1766098196.86,"pinyin":"gdbdxjkyjhhxzqtzjj","managers":[{"stockCode":"j101019652","stockType":"fund_manager","exchange":"fm","tickerId":261020244630,"name":"朱剑涛"}]},"announcement":{"linkText":"光大保德信健康优加混合型证券投资基金2022年第1季度报告","linkUrl":"http://eid.csrc.gov.cn/fund/disclose/instance_show_pdf_id.do?instanceid=727073","linkType":"PDF","source":"csrc_pdf"}},{"_id":"69aecf337fea5b3eb04f8890","date":"2021-12-30T16:00:00.000Z","stockId":3000000012284,"sao":"健康优加产品成立于2021年8月份，2021年度处于建仓期，同期申万医药行业指数下跌4.2%，健康优加净值下跌2.93%，表现略好于指数，主要是建仓期仓位较低的正贡献。出于谨慎原则，我们在建仓初期仓位较低，一是当时医药核心个股处于相对较高的估值位置，二是市场对于医药个股的持股集中度相对较高。21年下半年医药板块整体表现偏弱，我们在市场回调的过程中不断提高仓位。此外我们在四季度也提前布局了一些低估值、基本面转好的中药公司，按照我们一贯坚持的均衡成长的方向不断完善组合。","declarationDate":"2022-01-23T16:00:00.000Z","lastUpdated":"2026-03-09T13:46:27.303Z","mo":"2022年1月PPI同比增加9.1%，前值增10.3%，环比-0.4%。1月CPI同比增加0.9%，前值增1.5%，环比0.4%。1月新增社融6.17万亿，创历史新高。国内稳增长、宽信用的大背景下，我们对证券市场并没有那么悲观。2022年1月医药行业下跌14.94%，是近十年来单月第二大跌幅。市场似乎对医药极为悲观，21年公募基金四季报显示，公募基金整体对医药严重低配。做为医药行业研究和投资的一名老兵，我们对医药行业还是相对乐观的。疫情给了我们中国CXO企业快速登上世界舞台的机会，给了我们疫苗和IVD企业快速收获利润的机会，而这些利润将支撑这些企业走上自主创新、丰富产品线等未来长期发展之路。毫无疑问，中国的医药企业终会依靠实力登上世界舞台，机会的来临使得这些企业现金流更充裕，能够坚持更久，目的地不会改变。我们整体还是坚持选股标准，坚守能力圈，赚业绩的钱。投资方向上，我们买入了一些前期调整幅度较大，业绩较好的行业及个股，后续我们会尽力继续挖掘一些底部超预期的个股。","fund":{"_id":3000000012284,"__csrcFundId":9556,"stockCode":"012284","shortName":"光大保德信健康优加混合(012284)","fundSecondLevel":"hybrid","stockType":"fund","areaCode":"cn","market":"a","tickerId":12284,"masterFundFlag":1,"lastUpdated":"2026-04-30T23:14:27.111Z","status":"normal","exchange":"jj","name":"光大保德信健康优加混合型证券投资基金","fundCollectionId":4000050360000,"currency":"CNY","inceptionDate":"2021-08-04T16:00:00.000Z","followedNum":6,"masterFundShortName":"光大保德信健康优加混合","setUpDate":"2021-08-04T16:00:00.000Z","setUpAssetScale":1766098196.86,"setUpShares":1766098196.86,"pinyin":"gdbdxjkyjhhxzqtzjj","managers":[{"stockCode":"j101019652","stockType":"fund_manager","exchange":"fm","tickerId":261020244630,"name":"朱剑涛"}]},"announcement":{"linkText":"光大保德信健康优加混合型证券投资基金2021年年度报告","linkUrl":"http://eid.csrc.gov.cn/fund/disclose/instance_show_pdf_id.do?instanceid=713092","linkType":"PDF","source":"csrc_pdf"}}]}